메뉴 건너뛰기




Volumn 93, Issue 3, 2012, Pages 878-882

Heparin brand is associated with postsurgical outcomes in children undergoing cardiac surgery

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; HEPARIN;

EID: 84857574318     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.09.048     Document Type: Article
Times cited : (10)

References (27)
  • 1
    • 5344266145 scopus 로고    scopus 로고
    • Cardiopulmonary bypass after 50 years
    • L.H. Edmunds Cardiopulmonary bypass after 50 years N Engl J Med 351 2004 1603 1606
    • (2004) N Engl J Med , vol.351 , pp. 1603-1606
    • Edmunds, L.H.1
  • 2
    • 78650356248 scopus 로고    scopus 로고
    • Coagulation considerations for infants and children undergoing cardiopulmonary bypass
    • M.P. Eaton, E.M. Iannoli Coagulation considerations for infants and children undergoing cardiopulmonary bypass Paediatr Anaesth 21 2011 31 42
    • (2011) Paediatr Anaesth , vol.21 , pp. 31-42
    • Eaton, M.P.1    Iannoli, E.M.2
  • 3
    • 0036945831 scopus 로고    scopus 로고
    • Coagulation abnormalities in patients with cyanotic congenital heart disease
    • D.K. Tempe, S. Virmani Coagulation abnormalities in patients with cyanotic congenital heart disease J Cardiothorac Vasc Anesth 16 2002 752 765
    • (2002) J Cardiothorac Vasc Anesth , vol.16 , pp. 752-765
    • Tempe, D.K.1    Virmani, S.2
  • 4
    • 77950802426 scopus 로고    scopus 로고
    • Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery
    • C.E. Gruenwald, C. Manlhiot, L. Crawford-Lean Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery J Extra Corpor Technol 42 2010 9 19
    • (2010) J Extra Corpor Technol , vol.42 , pp. 9-19
    • Gruenwald, C.E.1    Manlhiot, C.2    Crawford-Lean, L.3
  • 5
    • 80053568379 scopus 로고    scopus 로고
    • Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery
    • C. Manlhiot, I.B. Menjak, L.R. Brandao Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery Circulation 124 2011 1511 1519
    • (2011) Circulation , vol.124 , pp. 1511-1519
    • Manlhiot, C.1    Menjak, I.B.2    Brandao, L.R.3
  • 6
    • 78449282703 scopus 로고    scopus 로고
    • Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass
    • C. Gruenwald, C. Manlhiot, A.K. Chan Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass J Am Coll Cardiol 56 2010 1794 1802
    • (2010) J Am Coll Cardiol , vol.56 , pp. 1794-1802
    • Gruenwald, C.1    Manlhiot, C.2    Chan, A.K.3
  • 7
    • 0033014430 scopus 로고    scopus 로고
    • Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery
    • G.D. Williams, S.L. Bratton, C. Ramamoorthy Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery Anesth Analg 89 1999 57 64
    • (1999) Anesth Analg , vol.89 , pp. 57-64
    • Williams, G.D.1    Bratton, S.L.2    Ramamoorthy, C.3
  • 9
    • 78649687391 scopus 로고    scopus 로고
    • Characterization of currently marketed heparin products: Reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests
    • A.M. Brustkern, L.F. Buhse, M. Nasr, A. Al-Hakim, D.A. Keire Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests Anal Chem 82 2010 9865 9870
    • (2010) Anal Chem , vol.82 , pp. 9865-9870
    • Brustkern, A.M.1    Buhse, L.F.2    Nasr, M.3    Al-Hakim, A.4    Keire, D.A.5
  • 10
    • 79251584385 scopus 로고    scopus 로고
    • A new approach for heparin standardization: Combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis
    • M.A. Lima, T.R. Rudd, E.H. de Farias A new approach for heparin standardization: combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis PLoS One 6 2011 e15970
    • (2011) PLoS One , vol.6 , pp. 15970
    • Lima, M.A.1    Rudd, T.R.2    De Farias, E.H.3
  • 11
    • 70449569318 scopus 로고    scopus 로고
    • Heparins: Process-related physico-chemical and compositional characteristics, fingerprints and impurities
    • L. Liverani, G. Mascellani, F. Spelta Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities Thromb Haemost 102 2009 846 853
    • (2009) Thromb Haemost , vol.102 , pp. 846-853
    • Liverani, L.1    Mascellani, G.2    Spelta, F.3
  • 12
    • 2442628599 scopus 로고    scopus 로고
    • The Aristotle score: A complexity-adjusted method to evaluate surgical results
    • F. Lacour-Gayet, D. Clarke, J. Jacobs The Aristotle score: a complexity-adjusted method to evaluate surgical results Eur J Cardiothorac Surg 25 2004 911 924
    • (2004) Eur J Cardiothorac Surg , vol.25 , pp. 911-924
    • Lacour-Gayet, F.1    Clarke, D.2    Jacobs, J.3
  • 13
    • 0034255628 scopus 로고    scopus 로고
    • Presentation of the International Nomenclature for Congenital Heart Surgery the long way from nomenclature to collection of validated data at the EACTS
    • F. Lacour-Gayet, B. Maruszewski, C. Mavroudis, J.P. Jacobs, M.J. Elliott Presentation of the International Nomenclature for Congenital Heart Surgery The long way from nomenclature to collection of validated data at the EACTS Eur J Cardiothorac Surg 18 2000 128 135
    • (2000) Eur J Cardiothorac Surg , vol.18 , pp. 128-135
    • Lacour-Gayet, F.1    Maruszewski, B.2    Mavroudis, C.3    Jacobs, J.P.4    Elliott, M.J.5
  • 14
    • 0024456056 scopus 로고
    • Anti-thrombin activities of heparin Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin
    • B. Bray, D.A. Lane, J.M. Freyssinet, G. Pejler, U. Lindahl Anti-thrombin activities of heparin Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin Biochem J 262 1989 225 232
    • (1989) Biochem J , vol.262 , pp. 225-232
    • Bray, B.1    Lane, D.A.2    Freyssinet, J.M.3    Pejler, G.4    Lindahl, U.5
  • 15
    • 0021061174 scopus 로고
    • Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
    • J. Choay, M. Petitou, J.C. Lormeau, P. Sinay, B. Casu, G. Gatti Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity Biochem Biophys Res Commun 116 1983 492 499
    • (1983) Biochem Biophys Res Commun , vol.116 , pp. 492-499
    • Choay, J.1    Petitou, M.2    Lormeau, J.C.3    Sinay, P.4    Casu, B.5    Gatti, G.6
  • 16
    • 0025962740 scopus 로고
    • Antithrombin: Structure and function
    • C.W. Pratt, F.C. Church Antithrombin: structure and function Semin Hematol 28 1991 3 9
    • (1991) Semin Hematol , vol.28 , pp. 3-9
    • Pratt, C.W.1    Church, F.C.2
  • 17
    • 0027189646 scopus 로고
    • A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection
    • R.J. Olds, D.A. Lane, C.H. Beresford, U. Abildgaard, P.M. Hughes, S.L. Thein A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection Genomics 16 1993 298 299
    • (1993) Genomics , vol.16 , pp. 298-299
    • Olds, R.J.1    Lane, D.A.2    Beresford, C.H.3    Abildgaard, U.4    Hughes, P.M.5    Thein, S.L.6
  • 21
    • 0014721845 scopus 로고
    • A collaborative study of heparins from different sources
    • D.R. Bangham, P.M. Woodward A collaborative study of heparins from different sources Bull World Health Organ 42 1970 129 149
    • (1970) Bull World Health Organ , vol.42 , pp. 129-149
    • Bangham, D.R.1    Woodward, P.M.2
  • 22
    • 0031870111 scopus 로고    scopus 로고
    • Do different heparin brands influence activated clotting times?
    • L. Dyck, R.M. Friesen Do different heparin brands influence activated clotting times? J Extra Corpor Technol 30 1998 73 76
    • (1998) J Extra Corpor Technol , vol.30 , pp. 73-76
    • Dyck, L.1    Friesen, R.M.2
  • 23
    • 0034533546 scopus 로고    scopus 로고
    • Characterization of unfractionated heparin: Comparison of materials from the last 50 years
    • B. Mulloy, E. Gray, T.W. Barrowcliffe Characterization of unfractionated heparin: comparison of materials from the last 50 years Thromb Haemost 84 2000 1052 1056
    • (2000) Thromb Haemost , vol.84 , pp. 1052-1056
    • Mulloy, B.1    Gray, E.2    Barrowcliffe, T.W.3
  • 24
    • 46749120559 scopus 로고    scopus 로고
    • Heparin is procoagulant in the absence of antithrombin
    • S.A. Smith, J.H. Morrissey Heparin is procoagulant in the absence of antithrombin Thrombos Haemostas 100 2008 160 162
    • (2008) Thrombos Haemostas , vol.100 , pp. 160-162
    • Smith, S.A.1    Morrissey, J.H.2
  • 25
    • 0028785452 scopus 로고
    • Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
    • J. Hirsh, R. Raschke, T.E. Warkentin, J.E. Dalen, D. Deykin, L. Poller Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety Chest 108 Suppl 1995 258 275
    • (1995) Chest , vol.108 , Issue.SUPPL. , pp. 258-275
    • Hirsh, J.1    Raschke, R.2    Warkentin, T.E.3    Dalen, J.E.4    Deykin, D.5    Poller, L.6
  • 26
    • 0025254425 scopus 로고
    • Heparin dosing and monitoring for cardiopulmonary bypass A comparison of techniques with measurement of subclinical plasma coagulation
    • G.P. Gravlee, W.S. Haddon, H.K. Rothberger Heparin dosing and monitoring for cardiopulmonary bypass A comparison of techniques with measurement of subclinical plasma coagulation J Thorac Cardiovasc Surg 99 1990 518 527
    • (1990) J Thorac Cardiovasc Surg , vol.99 , pp. 518-527
    • Gravlee, G.P.1    Haddon, W.S.2    Rothberger, H.K.3
  • 27
    • 79956088575 scopus 로고    scopus 로고
    • A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery
    • Y. Fromes, K. Daghildjian, L. Caumartin A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery Anaesthesia 66 2011 488 492
    • (2011) Anaesthesia , vol.66 , pp. 488-492
    • Fromes, Y.1    Daghildjian, K.2    Caumartin, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.